Related by context. All words. (Click for frequent words.) 69 Adverse Event 68 Venous Thromboembolism 67 Cardiovascular Events 66 Cardiovascular Outcomes 66 Medication Errors 65 Myocardial Ischemia 65 Survival Benefit 65 Adverse Reactions 65 Patients Undergoing 64 Serious Adverse Events 64 Reduced Risk 64 Patients Receiving 64 Kidney Function 64 Antibiotic Use 63 Adjuvant Chemotherapy 63 Postmarketing 63 Liver Failure 63 Carotid Endarterectomy 63 Hepatotoxicity 63 Dual Antiplatelet Therapy 63 Rheumatoid Arthritis Patients 62 Combination Treatment 62 Fungal Infections 62 Randomized Controlled Trials 62 Fracture Risk 62 Patient Outcomes 62 Bloodstream Infections 62 Patients Treated 62 Kidney Failure 62 Survival Rates 62 Newly Diagnosed Multiple Myeloma 62 Non Inferiority 62 Intracerebral Hemorrhage 62 Long Term Outcomes 62 Elderly Patients 61 Regimens 61 Investigational Drug 61 Thrombotic 61 Reduces Mortality 61 Colorectal Cancer Patients 61 Lung Injury 61 Valvular Heart Disease 61 Renal Function 61 Pediatric Patients 61 Heart Failure Patients 61 Who Underwent 61 Breast Cancer Recurrence 61 Reduce Mortality 61 Anticoagulation 61 Antiplatelet Therapy 61 Stem Cell Transplants 61 Shows Efficacy 61 Carotid Stenting 61 Suicidal Behavior 61 Prolongs Survival 61 Pneumococcal Vaccine 61 Progressive Multifocal Leukoencephalopathy 61 Surgical Procedures 60 Severe Asthma 60 Improves Outcomes 60 Endometrial Cancer 60 Clinical Efficacy 60 Unfractionated Heparin 60 Treating Chronic 60 Life Threatening 60 Bone Mineral Density 60 Efficacy Endpoints 60 Estrogen Therapy 60 Statistically Significant 60 Premature Infants 60 Clinical Outcomes 60 Obese Patients 60 Cognitive Impairment 60 Clinical Outcome 60 Postmenopausal Women 60 Psychiatric Disorders 60 Septic Shock 60 Pain Medication 60 Ischemic Stroke 60 Improves Survival 60 Acute Coronary Syndromes 60 Hematopoietic Stem Cell Transplantation 60 Chronic Lyme Disease 60 Suicidal Ideation 60 Preterm Delivery 60 Overactive Bladder 60 Prostate Cancer Patients 60 Allergic Rhinitis 60 Localized Prostate Cancer 60 Polypharmacy 60 Kidney Transplantation 59 Appears Safe 59 Clostridium difficile Infection 59 Demonstrates Positive 59 Acute Myocardial Infarction 59 Nosocomial 59 MRSA Infections 59 hematological adverse 59 ST Segment Elevation 59 Chronic Renal Failure 59 Transplant Patients 59 Increased Mortality 59 Anticoagulants 59 Multiple Myeloma Patients 59 Diabetic Patients 59 Acne Drug 59 Inflammatory Markers 59 Proves Effective 59 Colorectal Cancer Screening 59 Advanced Melanoma 59 Childhood Vaccinations 59 Meta Analysis 59 Invasive Breast Cancer 59 Orthostatic Hypotension 59 Hip Fractures 59 Statin Therapy 59 Androgen Deprivation Therapy 59 Cardiovascular Risk 59 Coronary Angiography 59 Renal Cell Carcinoma 59 Comorbidities 59 Hip Fracture 59 Prostate Cancers 59 Renal Anemia 59 Prophylaxis 59 severe hypersensitivity reactions 59 Guideline Update 59 Prostate Surgery 59 Resistant Hypertension 59 Advanced Prostate Cancer 59 Coronary Artery Bypass Surgery 59 Radiation Exposure 59 Acute Pancreatitis 59 Investigational Agent 59 Rotavirus Vaccine 59 Deep Venous Thrombosis 59 Acute Decompensated Heart Failure 59 Diastolic Heart Failure 59 Breast Cancers 59 Skin Lesions 59 invasive aspergillosis 58 Gestational Diabetes 58 Sustained Efficacy 58 Immunosuppression 58 Inhaled Steroids 58 Combo Therapy 58 Percutaneous Coronary Intervention 58 Randomized Trials 58 Prognostic Factors 58 Suicidality 58 Radical Prostatectomy 58 Hemorrhagic Stroke 58 Beta Blocker 58 Malignant Glioma 58 Neoadjuvant Chemotherapy 58 Thrombolysis 58 Antibiotic Treatment 58 Coronary Artery Bypass Graft 58 Critically Ill Patients 58 Beta Blockers 58 Functional Outcomes 58 Infarction 58 Antipsychotic Medications 58 Kidney Transplants 58 Acute Heart Failure 58 Nesiritide 58 Bacterial Infections 58 Sleep Disordered Breathing 58 Breast Cancer Patients 58 Antiviral Drugs 58 Respiratory Infections 58 Endocarditis 58 Eye Infections 58 Exacerbations 58 Drug Coated Stents 58 Radiofrequency Ablation 58 fatal anaphylactic 58 Knee Osteoarthritis 58 Laryngeal Cancer 58 Hemolysis 58 Pooled Analysis 58 Glatiramer Acetate 58 Urinary Tract Infections 58 Epilepsy Drugs 58 Community Acquired Pneumonia 58 ALT flares 58 Systematic Review 58 Opioid Use 58 Pre Eclampsia 58 Treated Patients 57 Anticoagulant 57 Asymptomatic 57 Recurrent Stroke 57 receiving VELCADE 57 Gastric Cancer 57 Hypotension 57 myopathy rhabdomyolysis 57 Antitumor Activity 57 Stent Thrombosis 57 Hospitalized Patients 57 Blood Thinner 57 HCV Protease Inhibitor 57 Vitamin D Deficiency 57 Immunologic 57 Urinary Incontinence 57 Genital Herpes 57 Osteoporosis Drugs 57 Dialysis Patients 57 Drug Interactions 57 Toxicities 57 hematologic adverse 57 Allergic Reactions 57 Multicenter Trial 57 Approvable 57 Differential Diagnosis 57 Cholesterol Levels 57 ER Visits 57 Aortic Valve Replacement 57 Radiation Dose 57 Glycemic Control 57 venous thromboembolic disease 57 Severe Sepsis 57 Serious Adverse Event 57 Blood Clots 57 Pulmonary Arterial Hypertension 57 Thromboembolism 57 Castration Resistant Prostate Cancer 57 Clinical Practice Guidelines 57 Organ Rejection 57 Colorectal Screening 57 Minimally Invasive Treatment 57 Abdominal Pain 57 BANZEL 57 Gene Mutation 57 Newly Diagnosed Breast Cancer 57 Pesticide Exposure 57 Genetic Variations 57 Malignancies 57 Quality Indicators 57 Readmissions 57 Pressure Ulcers 57 Venous Thrombosis 57 Anemia Drug 57 Illicit Drug Use 57 Heartburn Drugs 57 Rectal Cancer 57 Prospective Multicenter 57 Cholesterol Lowering Drug 57 Antidepressant Use 57 Improved Survival 57 Hematologic 57 Platelet Inhibition 57 Contraceptive Use 57 Myelodysplastic Syndromes 57 Psychiatric Illness 57 Unstable Angina 57 Hypoglycemia 57 Catheter Ablation 57 Chronic Cough 57 Gene Mutations 57 Mortality Risk 57 Motor Vehicle Crashes 56 Hemodialysis Patients 56 Physical Function 56 Placebo Effect 56 Hazardous Drugs 56 Disease Progression 56 Thromboembolic 56 Breast Cancer Treatment 56 Osteoporosis Drug 56 Subgroup Analysis 56 Prostatectomy 56 Drug Approvals 56 Helicobacter Pylori 56 Protease Inhibitors 56 Drug Prevents 56 Hepatitis C Virus 56 Endovascular Repair 56 Coronary Revascularization 56 Antihypertensive 56 Catheter Associated 56 Metastatic Prostate Cancer 56 Osteoarthritis Patients 56 Potentially Fatal 56 Fusarium Keratitis 56 Stem Cell Treatment 56 Antiepileptic Drug 56 Alcohol Consumption 56 Screening Mammography 56 Bacterial Infection 56 Lung Cancers 56 Cigarette Smoke 56 Depressive Symptoms 56 Bare Metal Stents 56 Skin Infections 56 Arrhythmias 56 Breast Tumors 56 Investigational Treatment 56 Kidney Transplant Patients 56 Treating Depression 56 Arthritis Drugs 56 QTc prolongation 56 ARIXTRA R 56 Renal Failure 56 Drug Utilization 56 Proton Pump Inhibitors 56 Prognostic Value 56 Short Stature 56 hepatic failure 56 H#N# Flu Virus 56 Intracranial 56 Pain Relievers 56 Long Term Survival 56 Follicular Lymphoma 56 Potent Antiviral Activity 56 Cold Meds 56 Bivalirudin 56 Heart Ailments 56 Counterfeit Drugs 56 Epilepsy Drug 56 Ischemic 56 Genes Linked 56 Package Insert 56 Lipid Levels 56 Fondaparinux 56 Epoetin Alfa 56 Genital Warts 56 Uterine Fibroid Embolization 56 Hyperkalemia 56 Genetic Variation 56 Randomized Controlled 56 Acute Pain 56 Treatment Naive Patients 56 Blood Transfusions 56 Angioedema 56 ARCOXIA 56 Aggressive Prostate Cancer 56 Bacteremia 56 FDA Panel Recommends 56 Anti Clotting Drug 56 SAEs 56 Mortality Rates 56 Chronic Kidney 55 Pregnancy Outcomes 55 Prostate Biopsy 55 Virus Infection 55 FDA Approvals 55 Diabetic Foot Ulcer 55 Drug Combo 55 Foodborne Illness 55 ACE Inhibitors 55 Renal Impairment 55 Cardiovascular Disease Risk 55 postmarketing 55 ocular adverse 55 Corticosteroids 55 Renal Cancer 55 Ear Infections 55 Smallpox Vaccination 55 Recurrences 55 Metastases 55 Blood Pressure Reduction 55 Generalized Anxiety Disorder 55 Migraine Headaches 55 Neoplasms 55 Preterm Labor 55 Iron Deficiency 55 Unresectable 55 ADEs 55 Treatment Resistant 55 Osteoporosis Treatment 55 Pap Smears 55 hepatic dysfunction 55 HPA axis suppression 55 Medication Adherence 55 Diagnostic Tests 55 Prostate Cancer Treatment 55 Anemia Drugs 55 Contact Dermatitis 55 Chronic Constipation 55 Oral Fingolimod 55 INFERGEN 55 Chronic Heart Failure 55 gastrointestinal adverse reactions 55 Bipolar Mania 55 Secondhand Smoke Exposure 55 Blocked Arteries 55 Nebulized 55 Prolonged Survival 55 Cesarean Delivery 55 Gum Disease 55 Oral Cavity 55 Prophylactic Treatment 55 Myocardial Infarction 55 Gender Differences 55 Left Ventricular Hypertrophy 55 Antipsychotic Drug 55 Tiotropium 55 Increased Risk 55 Post Operative 55 Ventricular Tachycardia 55 EXJADE 55 LYSTEDA 55 Chronic Sinusitis 55 Radiofrequency Ablation RFA 55 Psychological Distress 55 Telithromycin 55 ACCF AHA 55 Peanut Allergy 55 Capecitabine 55 TEAEs 55 Lung Cancer Patients 55 Cesarean Section 55 Adverse Drug 55 thrombotic events 55 Atypical Antipsychotics 55 Better Outcomes 55 thromboembolism 55 Prostate Cancer Recurrence 55 Atypical Hemolytic Uremic Syndrome 55 Colorectal 55 Shingles Vaccine 55 Tigecycline 55 thromboembolic events 55 Liver Transplant Patients 55 Microalbuminuria 55 Aortic Stenosis 55 Meningococcal Disease 55 Cervical Spine 55 Cardiovascular Risk Factors 55 Respiratory Symptoms 55 Respiratory Illness 55 Risk Stratification 55 Hospital Acquired Infections 55 Patients Treated With 55 Early Diagnosis 55 Anthracycline 55 Levels Linked 55 Vertebral Fractures 55 Increases Risk 55 Prolongs Life 55 Maternal Deaths 55 Drug Shows Promise 55 Balloon Angioplasty 55 Iron Overload 55 Diagnostic Criteria 55 Embolization 55 Erectile Dysfunction Drugs 55 Staph Infections 55 Seasonal Influenza 55 Drug Resistant TB 55 Diuretic 55 PET Scans 55 Thrombocytopenia 55 Relapsed Multiple Myeloma 55 Premature Birth 55 Ectopic Pregnancy 55 AA Amyloidosis 55 Sleep Disturbance 55 Thyroid Cancer 55 Endothelial Function 55 Stent thrombosis 55 Myeloma Patients 55 Aggressive Behavior 55 Ischaemic 55 Osteonecrosis 55 Preterm Infants 55 Irritable Bowel 55 cholecystitis 55 Recurrence 55 FDA Adverse Event 55 adverse reactions 55 Patient Populations 55 Commonly Used 55 Total Knee Arthroplasty 54 Skin Cancers 54 Gene Linked 54 Prostate Cancer Screening 54 Reversible Posterior Leukoencephalopathy Syndrome 54 Genetic Variants 54 Randomized Controlled Trial 54 Hematological Cancers 54 Anxiety Depression 54 intracranial hemorrhage ICH 54 Pneumococcal Conjugate Vaccine 54 Mucositis 54 Blood Pressure Drug 54 Chronic Hepatitis B 54 Asthma Symptoms 54 Stenting 54 Outcome Measures 54 Contaminated Heparin 54 Stronger Warnings 54 Transplant Rejection 54 Premenopausal Women 54 Rofecoxib 54 Inhaled Liposomal Ciprofloxacin 54 Gastric Bypass Surgery 54 eosinophilic pneumonia 54 Chronic HCV 54 paroxetine Paxil 54 Aneurysm 54 Recurrent Breast Cancer 54 Lowers Risk 54 Lymphoma Patients 54 tumor lysis syndrome 54 Herbal Supplements 54 HER2 Positive Breast Cancer 54 Preterm Birth 54 Venous thromboembolism 54 Cardiac Arrest Patients 54 treatment emergent adverse 54 events SAEs 54 Postmenopausal 54 H#N# Pandemic 54 Pulmonary Artery 54 Hyperlipidemia 54 Fabry Disease 54 Antiretroviral Therapy 54 WARNINGS Myopathy Rhabdomyolysis 54 Chronic Bronchitis 54 leiomyomas 54 Genetic Mutation 54 Pafuramidine 54 Treatment Reduces 54 Subtypes 54 Elevated Levels 54 ATACAND 54 Atmospheric Carbon Dioxide 54 Antidepressants Linked 54 Hemoglobin Levels 54 Catheterization 54 Acute Otitis Media 54 Nosocomial Pneumonia 54 Heart Defects 54 Disease Outbreaks 54 Thrombus 54 Aneurysm Repair 54 Cost Effectiveness 54 Viral Load 54 Mental Distress 54 NOLVADEX 54 FDA Warns Against 54 Infection Rate 54 Restenosis 54 Arthritis Drug 54 Malignant Melanoma 54 Radiation Induced 54 Adjuvant Breast Cancer 54 Chronic Insomnia 54 Therapy Improves 54 Sleep Duration 54 acute myocardial infarction MI 54 rFVIIa 54 ARIXTRA 54 Doctors Warn 54 Symptom Improvement 54 Ovarian Cancer Patients 54 Drug Resistant Bacteria 54 Certain Cancers 54 syncopal 54 AVANDIA 54 Misdiagnosis 54 Asthma Treatment 54 antimicrobial prophylaxis 54 Gout Drug 54 Bone Fractures 54 Respiratory Distress 54 Gene Variant 54 Mycophenolate Mofetil 54 Renal impairment 54 deep venous thromboses 54 Catheter Related Bloodstream Infections 54 Renal Artery 54 Obesity Linked 54 Diabetic Foot Ulcers 54 Morbidity Mortality 54 Ethnic Disparities 54 Could Prevent 54 Pain Meds 54 events AEs 54 hemorrhagic complications 54 perioperative complications 54 Heart Stents 54 Enlarged Prostate 54 Antipsychotic Drugs 54 Breast Biopsies 54 Drug Resistant 54 Adenomas 54 hyperkalemia 54 Lung Transplants 54 Cervical Cancer Vaccine 54 Carotid Artery 54 Colorectal Adenomas 54 angioedema 54 Cardiac Function 54 Perinatal Mortality 54 Salmeterol 54 Warfarin Coumadin 54 Less Invasive 54 Breast Cancer Risk 54 Flu Vaccines 54 Malformations 54 NOMID 54 Non Alcoholic Fatty 54 Colorectal Cancer Risk 54 Foodborne Pathogens 54 National Confidential Enquiry 54 Rotavirus Vaccines 54 Squamous Cell Carcinoma 53 Disease Severity 53 Complication Rates 53 Low Incidence 53 hepatotoxicity 53 Blood Clot 53 Vertebral Compression Fractures 53 Autoimmune Disease 53 Survival Rate 53 ARCALYST ® 53 Peritoneal Mesothelioma 53 antiplatelet medications 53 Aortic Dissection 53 hypoglycemic events 53 Practice Guideline 53 hypoglycaemic episodes 53 Asthma Attacks 53 Renal dysfunction 53 Coronary Artery 53 Vascular Disease 53 Fluoroquinolones 53 Cervical Disease 53 Drug Fails 53 Lung Cancer Survival 53 Colorectal Cancers 53 lactic acidosis 53 Intubation 53 Kidney Donors 53 Triptan 53 Anthrax Vaccine 53 Birth Defect 53 Pneumococcal Disease 53 TMP SMX 53 Patient Outcome 53 Surgical Treatment 53 Aortic Valve 53 Invasive Pneumococcal Disease 53 Node Positive 53 Cancer Treatments 53 Test Detects 53 Prostate Screening 53 Inhaled Insulin 53 Investigational Compound 53 Inhaled Nitric Oxide 53 Premature Deaths 53 Predict Risk 53 Drug Overdoses 53 Hysterectomy 53 Genetic Mutations 53 haematologic 53 Uterine Fibroids 53 Prostate Cancer Risk 53 Skeletal Muscle 53 Drug Makers 53 Parenteral Nutrition 53 bacteraemia 53 Carbon Monoxide Poisoning 53 Hospital Readmissions 53 hematological toxicities 53 Related Mortality 53 Prescription Medications 53 Experimental Vaccine 53 Radiation Doses 53 Antidepressant Drug 53 Drug Combinations 53 Torsades de Pointes 53 Iatrogenic 53 Carcinoma 53 intravenous bisphosphonates 53 Intervention Trial 53 Novel Antibiotic 53 Migraine Headache 53 Treatable 53 Egg Freezing 53 hemorrhagic cystitis 53 colorectal liver metastases 53 Blood Clot Risk 53 Peritoneal Dialysis 53 Immunosuppressant 53 Appropriateness Criteria 53 pancytopenia 53 Postmarket 53 Watchful Waiting 53 Malpractice Lawsuits 53 Ovarian Cancers 53 Osteoporotic 53 Heart Transplant Recipients 53 Total Hip Replacement 53 Occupational Exposure 53 aseptic meningitis 53 Comparative Effectiveness 53 heparin induced thrombocytopenia 53 Blood Pressure Drugs 53 Antipsychotic 53 Racial Disparities 53 Patients Suffering 53 Decompensated 53 abacavir Ziagen 53 Otitis Media 53 Anaemia 53 Percutaneous Coronary Interventions 53 Postherpetic Neuralgia 53 Afib 53 Lung Cancer Drug 53 Statin Use 53 Sustained Reduction 53 Treatment Outcome 53 GnRH agonists 53 Tonsillectomy 53 Moderate Drinking 53 Prospective Cohort Study 53 placebo controlled studies 53 HPV Vaccination 53 Obese Teens 53 Immune Responses 53 Naturally Occurring 53 mycophenolate mofetil 53 Infection Rates 53 Retreatment 53 Comorbid 53 dual endothelin receptor antagonist 53 Elective Surgery 53 Serious adverse reactions 53 Intravenous Formulation 53 Endarterectomy 53 Adverse events 53 Alternative Treatments 53 Candesartan 53 intracerebral hemorrhage 53 unstable angina pectoris 53 Kidney Disease Patients 53 Sexual Function 53 Potentially Harmful 53 FluCAM arm 53 Hypocalcemia 53 Prostate Cancer Surgery 53 Childhood Asthma 53 Unapproved Drugs 53 Kidney Stones 53 Negative Effects 53 Brain Tumors 53 MYCAMINE 53 symptomatic hyponatremia 53 Lung Cancer Risk 53 Neurophysiological 53 Clinical Guideline 53 HCV Genotype 53 Slow Progression 53 primary dysmenorrhoea 53 Chronic Wounds 53 Breast Tissue 53 Acute Renal Failure 53 perioperative mortality 53 Neoadjuvant 53 Neonates 53 laboratory abnormalities 52 Hypersensitivity 52 Premature Births 52 upper gastrointestinal bleeding 52 Hypersensitivity reactions 52 Adalimumab 52 Perindopril 52 postmarketing adverse 52 Eye Diseases 52 Fecal Incontinence 52 Cholesterol Drug 52 Improve Diagnosis 52 Skin Infection 52 Antifungal 52 Heart Transplants 52 Panel Advises 52 Stress Incontinence 52 Tumor Growth 52 hypersensitivity reactions 52 Rabies Vaccine 52 Fibromyalgia Pain 52 Novel Method 52 Boosts Survival 52 infliximab Remicade 52 Antiretroviral Drug 52 Juvenile Idiopathic Arthritis 52 cardiac toxicity 52 hyperbilirubinemia 52 elevated ALT 52 Child Abuse Cases 52 beta blocker therapy 52 Colon Polyps 52 anaphylactoid reactions 52 Antimicrobial Resistance 52 Vaccine Adverse Events 52 prolonged QT interval 52 Fertility Treatment 52 Clinical Evaluation 52 Pelvic Organ Prolapse 52 nonadherence 52 Vitamin D Supplementation 52 Macular Edema 52 Meets Primary Endpoint 52 Nutritional Needs 52 dermatologic reactions 52 Schizophrenia Treatment 52 Hepatitis C Patients 52 Known hypersensitivity 52 Lymph Node 52 Proteinuria 52 Racial Disparity 52 Total Hip Arthroplasty 52 Exacerbation 52 Delayed Graft Function 52 Coronary Artery Calcium 52 Meningitis Vaccine 52 Vulvar 52 discontinuations due 52 Smoking Cessation Programs 52 Shown Effective 52 Brain Aneurysms 52 Smoking Linked 52 Cognitive Function 52 Itraconazole 52 serotonin syndrome 52 Infected Patients 52 Psoriasis Drug 52 Nonalcoholic Fatty Liver Disease 52 Mental Illnesses 52 Inflammatory Disease 52 Esophageal Cancer 52 Showed Significant 52 Antibiotic Resistant 52 Intracerebral 52 Treatment Outcomes 52 Mesothelioma Patients 52 Prenatal Screening 52 Genes Identified 52 Marrow Transplant 52 Related Deaths 52 headache abdominal pain 52 MRSA Infection 52 CABG Surgery 52 Liver Injury 52 Epileptic Seizures 52 Interstitial Cystitis 52 Seasonal Influenza Vaccine 52 periprocedural 52 Mitral Regurgitation 52 Needlestick 52 INVEGA ® 52 nonfatal cardiovascular 52 Excessive Sweating 52 LDL Cholesterol 52 ergotamine 52 pharmacodynamic parameters 52 Sinus Infections 52 Complication 52 induce orthostatic hypotension 52 Donor Organs 52 Diabetic Peripheral Neuropathy 52 Main Outcome Measure 52 Dementia Risk 52 adverse cytogenetics 52 neutropaenia 52 Opioid Addiction 52 Patient Satisfaction 52 Could Predict 52 Tardive dyskinesia 52 Etiology 52 Contralateral 52 Non Melanoma Skin 52 Neutropenia 52 Pharmacokinetics PK 52 Newly Diagnosed Patients 52 Meta Analyses 52 Insulin Sensitivity 52 Moxifloxacin 52 Low Birthweight 52 invasive candidiasis 52 Nasal Sprays 52 Metastatic Pancreatic Cancer 52 Oral Contraceptive 52 PRADAXA 52 Systolic Hypertension 52 Heel Pain 52 HACs 52 Prevent Child 52 Erythropoietic therapies may 52 drug eluting stent implantation 52 Bypass Surgery 52 treatment emergent AEs 52 Calcium Intake 52 Minimally Invasive Procedure 52 shuren calls 52 invasive fungal infections 52 Therapy Shows Promise 52 Childhood Immunizations 52 Heart Attacks 52 Diabetes Mellitus 52 Mortality Rate 52 Capsule Endoscopy 52 Capsular 52 Hospitalization Rates 52 included exfoliative dermatitis 52 Myelodysplastic Syndrome 52 Sudden Cardiac Death 52 Risk Behavior 52 Hormonal Therapy 52 nitrofurantoin 52 Stomach Ulcer 52 severe exacerbations 52 adrenal insufficiency 52 recurrent ischemic 52 Hepatitis B Vaccine 52 hypercholesterolaemia 52 Diagnosis Treatment 52 Sexual Dysfunction 52 Inflammatory Bowel Diseases 52 DOXIL 52 tegaserod 52 ischemic complications 52 Driver Distraction 52 reinfarction 52 Foodborne Illnesses 52 atherothrombotic 52 PROCRIT 52 Treatment Shows Promise 52 Mammogram Guidelines 52 infusion reactions 52 Birth Weight 52 Vasculitis 51 Primary Biliary Cirrhosis 51 Platinol ® 51 Often Misdiagnosed 51 FDA Approves Drug 51 Genetic Basis 51 severe hepatomegaly 51 ORENCIA ® 51 postoperative mortality 51 antiepileptics 51 Critically Ill 51 Hormone Refractory Prostate Cancer 51 Antibiotic 51 lumiracoxib 51 Influenza Vaccination 51 tardive dyskinesia TD 51 extrapyramidal symptoms 51 Stable Coronary Artery 51 nephrotoxicity 51 NICE Recommends 51 Adverse Event Reporting 51 Pregnancies 51 HIV Infections 51 NATRECOR ® 51 postoperative complication 51 Unsanitary Conditions 51 Corneal Transplant 51 Coronary Artery Bypass Grafting 51 Hospitalizations 51 RAPTIVA 51 Stress Induced 51 Myocardial 51 concomitant medications 51 ICD shocks 51 Cancer Incidence Mortality 51 Malignancy 51 Varies Widely 51 Extended Release 51 solifenacin 51 H2 receptor antagonists 51 Treatment Approaches 51 neuropsychiatric events 51 Coronary Intervention 51 Can Predict 51 Improving Patient Safety 51 Cervical Screening 51 Bone Fracture 51 quinolone antibiotics 51 Immunodeficiency 51 Adefovir 51 Uterine Cancer 51 Cytogenetic 51 sertraline Zoloft 51 Chronic Pelvic Pain 51 Male Contraceptive 51 Sleep Disturbances 51 Cognitive Decline 51 SF #v# 51 Postoperative complications 51 Protein Linked 51 renal toxicity 51 Deaths Caused 51 hypomagnesemia 51 labetalol